David J. Salant
Boston University
H-index: 65
North America-United States
Top articles of David J. Salant
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
C3d-Targeted factor H inhibits tissue complement in disease models and reduces glomerular injury without affecting circulating complement | Molecular Therapy | Fei Liu Sarah T Ryan Kelly C Fahnoe Jennifer G Morgan Anne E Cheung | 2024/2/20 |
Membranous nephropathy: Pathogenesis and etiology | Retrieved May | Laurence H Beck Salant DJ | 2023 |
Complement activation and effector pathways in membranous nephropathy | Andreas D Kistler David J Salant | 2023/12/21 | |
Podocyte-parietal epithelial cell interdependence in glomerular development and disease | Robert Bronstein Jesse Pace Yogesh Gowthaman David J Salant Sandeep K Mallipattu | 2023/5/1 | |
ZEB2 controls kidney stromal progenitor differentiation and inhibits abnormal myofibroblast expansion and kidney fibrosis | JCI insight | Sudhir Kumar Xueping Fan Hila Milo Rasouly Richa Sharma David J Salant | 2023/1/1 |
Membranous nephropathy: Clinical manifestations and diagnosis | Retrieved May | LH Beck David J Salant | 2023 |
Anti-ROBO2 antibodies, compositions, methods and uses thereof | 2022/6/21 | ||
POS-042 C3d-Directed Factor H Targeting Delivers Potent and Durable Complement Inhibition and Disease-Modifying Efficacy In Kidney and Skin Without Inhibiting Systemic Complement | Kidney International Reports | F Liu S Ryan K Fahnoe J Morgan K Bieber | 2022/6/1 |
C3d-Targeted Factor H Achieves Potent Tissue-Directed Complement Inhibition and Disease-Modifying Efficacy Without Affecting Systemic Complement | Fei Liu Sarah Ryan Kelly Fahnoe Jennifer Morgan Michael Storek | 2022/1/1 | |
Recombinant robo2 proteins, compositions, methods and uses thereof | 2021/7/15 | ||
Insights into Glomerular Filtration and Albuminuria. Reply. | The New England journal of medicine | Aurelie Edwards David Salant Thomas Benzing | 2021/7/1 |
PODO: trial design: phase 2 study of PF-06730512 in focal segmental glomerulosclerosis | Kidney International Reports | Laurence H Beck Jr Stephen P Berasi J Brian Copley Donal Gorman Daniel I Levy | 2021/6/1 |
Advancing nephrology: division leaders advise ASN | Clinical Journal of the American Society of Nephrology | Gregory L Braden Arlene Chapman David H Ellison Crystal A Gadegbeku Susan B Gurley | 2021/2/1 |
Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1–associated membranous nephropathy | The Journal of clinical investigation | George Haddad Johan M Lorenzen Hong Ma Noortje de Haan Harald Seeger | 2021/3/1 |
Podocyte-specific KLF4 is required to maintain parietal epithelial cell quiescence in the kidney | Science Advances | Jesse A Pace Robert Bronstein Yiqing Guo Yaqi Yang Chelsea C Estrada | 2021/9/3 |
Proteinas recombinantes robo2, composiciones, metodos y usos de las mismas | 2020/3/4 | ||
Refining our understanding of the PLA2R-antibody response in primary membranous nephropathy: looking forward, looking back | Journal of the American Society of Nephrology | Laurence H Beck Jr David J Salant | 2020/1/1 |
Complement deficiencies result in surrogate pathways of complement activation in novel polygenic lupus-like models of kidney injury | The Journal of Immunology | Sladjana Skopelja-Gardner Lucrezia Colonna Payton Hermanson Xizhang Sun Lena Tanaka | 2020/5/15 |
Proteínas recombinantes robo2, composiciones, métodos y usos de las mismas | 2020/4/1 | ||
Loss of roundabout guidance receptor 2 (Robo2) in podocytes protects adult mice from glomerular injury by maintaining podocyte foot process structure | The American Journal of Pathology | Anna Pisarek-Horowitz Xueping Fan Sudhir Kumar Hila M Rasouly Richa Sharma | 2020/4/1 |
Co-Authors
